The Côte d’ivoire Ethics Capacity Building Initiative (CECaBI) is a consortium of different partners whose objectives are to strengthen the knowledge and skills of the senior members of the National Ethics Committee for Life Sciences and Ivorian Authorities of Pharmaceutical Regulation (Autorités Ivoiriennes de Régulation Pharmaceutique (AIRP)), on how to conduct high-quality ethics reviews, ensure optimal protection of research participants, and effectively manage and coordinate clinical trials.
Pharmalys is part of this initiative. As such, Karim Bagaté, Director of Clinical Operations & Safety delivered a capacity building programme in Côte d’Ivoire in 2023. The training was delivered in two parts. The first one, in March 2023, was about the Good Clinical Practice (GCP) guidelines and site inspection. The second part, in October 2023 was a refresher on GCP with very practical exercises and workshops and a site inspection visit.
Pharmalys at the World Vaccine Congress Europe 2025: Marieme Ba calls for a “Come and Build” Approach to Strengthening LMICs Clinical Research Ecosystems
From 13 to 16 October 2025, Pharmalys Founder & CEO Marieme Ba attended the World Vaccine Congress Europe in Amsterdam, one of the most influential global gatherings for vaccine development, innovation, and cross-sector collaboration. This year’s edition brought...
